Related Experiment Videos

The Xmrk receptor tyrosine kinase is activated in Xiphophorus malignant melanoma

J Wittbrodt1, R Lammers, B Malitschek

  • 1Max-Planck Institute for Biochemistry, Martinsried, Germany.

The EMBO Journal
|November 1, 1992
PubMed

Insights

The Xmrk receptor tyrosine kinase is highly active in melanoma, potentially due to mutations. A HER-Xmrk chimera demonstrated potent transforming activity, confirming Xmrk

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Xmrk is a melanoma-inducing gene in Xiphophorus, encoding a tyrosine kinase family member.
  • Investigating Xmrk's biological function is challenging due to the absence of an identified ligand.
  • Understanding Xmrk signaling is crucial for melanoma research.

Purpose of the Study:

  • To characterize the signaling properties and biological function of the Xmrk receptor.
  • To examine the ligand-induced activity of a chimeric HER-Xmrk protein.

Main Methods:

  • Constructed a chimeric protein by replacing the Xmrk extracellular domain with the HER ligand-binding domain.
  • Assessed the activity and transforming potential of the chimeric HER-Xmrk protein.
  • Analyzed Xmrk's autophosphorylation activity in malignant melanoma.

Main Results:

  • Xmrk functions as a receptor tyrosine kinase with constitutive autophosphorylation activity.
  • This constitutive activity may result from activating mutations in the extracellular or transmembrane domains.
  • The HER-Xmrk chimera exhibited potent transforming activity in focus formation assays.

Conclusions:

  • Xmrk is a functional receptor tyrosine kinase implicated in melanoma.
  • Activating mutations may contribute to its high activity in malignant melanoma.
  • The HER-Xmrk chimera serves as a potent oncoprotein, validating Xmrk's role.

Related Concept Videos